MAM
Marotta Asset Management Portfolio holdings
AUM
$499M
This Quarter Return
+8.39%
1 Year Return
+9.14%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$416M
AUM Growth
+$416M
(+8.5%)
Cap. Flow
+$2.23M
Cap. Flow
% of AUM
0.54%
Top 10 Holdings %
Top 10 Hldgs %
53.16%
Holding
113
New
3
Increased
36
Reduced
50
Closed
7
Top Buys
Top Sells
| 1 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
$4.79M |
| 2 |
Vanguard Health Care ETF
VHT
|
$1.02M |
| 3 |
Schwab Short-Term US Treasury ETF
SCHO
|
$904K |
| 4 |
Truist Financial
TFC
|
$491K |
| 5 |
GSK
GSK
|
$464K |
Sector Composition
| 1 | Healthcare | 1.84% |
| 2 | Financials | 1.38% |
| 3 | Industrials | 1.1% |
| 4 | Technology | 1.05% |
| 5 | Consumer Discretionary | 0.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vanguard Real Estate ETF
VNQ
$34.1B
| $5.6M | 1.35% |
67,914
-4,087
| -6% | -$337K |
|
27
Franklin FTSE United Kingdom ETF
FLGB
$841M
| $5.28M | 1.27% |
230,936
-141
| -0.1% | -$3.23K |
|
28
Franklin FTSE Canada ETF
FLCA
$461M
| $5.2M | 1.25% |
174,762
+666
| +0.4% | +$19.8K |
|
29
SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.45B
| $5.11M | 1.23% |
78,934
-2,803
| -3% | -$181K |
|
30
SPDR S&P Biotech ETF
XBI
$5.29B
| $5.02M | 1.21% |
60,540
+4,575
| +8% | +$380K |
|
31
iShares MSCI Chile ETF
ECH
$709M
| $3.6M | 0.87% |
132,796
-4,325
| -3% | -$117K |
|
32
Vanguard Global ex-US Real Estate ETF
VNQI
$3.5B
| $3.47M | 0.84% |
84,055
-2,993
| -3% | -$124K |
|
33
Franklin FTSE South Korea ETF
FLKR
$180M
| $3.45M | 0.83% |
177,103
-6,074
| -3% | -$118K |
|
34
Vanguard Short-Term Treasury ETF
VGSH
$22.8B
| $3.4M | 0.82% |
58,798
+33,086
| +129% | +$1.91M |
|
35
SPDR S&P 600 Small Cap Value ETF
SLYV
$4B
| $3.01M | 0.72% |
40,545
-1,228
| -3% | -$91.1K |
|
36
Vanguard Value ETF
VTV
$143B
| $2.58M | 0.62% |
18,368
+2,271
| +14% | +$319K |
|
37
Vanguard Total Stock Market ETF
VTI
$524B
| $2.49M | 0.6% |
13,023
-611
| -4% | -$117K |
|
38
iShares Global Healthcare ETF
IXJ
$3.82B
| $2.11M | 0.51% |
24,914
-380
| -2% | -$32.3K |
|
|
39
Truist Financial
TFC
$59.8B
| $2.07M | 0.5% |
48,068
-11,402
| -19% | -$491K |
|
40
iShares Global Tech ETF
IXN
$5.69B
| $1.99M | 0.48% |
44,297
-1,099
| -2% | -$49.3K |
|
41
Wells Fargo
WFC
$258B
| $1.45M | 0.35% |
35,181
-449
| -1% | -$18.5K |
|
42
Vanguard Total Bond Market
BND
$133B
| $1.31M | 0.32% |
18,246
+12,318
| +208% | +$885K |
|
43
Microsoft
MSFT
$3.76T
| $1.3M | 0.31% |
5,433
+176
| +3% | +$42.2K |
|
44
Apple
AAPL
$3.54T
| $1.25M | 0.3% |
9,619
-222
| -2% | -$28.8K |
|
45
Novo Nordisk
NVO
$252B
| $1.21M | 0.29% |
8,942
-398
| -4% | -$53.9K |
|
46
General Dynamics
GD
$86.8B
| $1.14M | 0.27% |
4,577
-25
| -0.5% | -$6.2K |
|
47
Fidelity MSCI Real Estate Index ETF
FREL
$1.04B
| $994K | 0.24% |
+40,054
| New | +$994K |
|
48
Norfolk Southern
NSC
$62.4B
| $966K | 0.23% |
3,921
| – | – |
|
49
Schwab US Large-Cap Growth ETF
SCHG
$48B
| $923K | 0.22% |
16,609
-666
| -4% | -$37K |
|
50
AstraZeneca
AZN
$255B
| $916K | 0.22% |
13,507
-147
| -1% | -$9.97K |
|